2,227
Participants
Start Date
September 15, 2014
Primary Completion Date
February 21, 2020
Study Completion Date
April 15, 2020
Rivaroxaban (Xarelto, BAY59-7939)
Survey to measure physician awareness and understanding of the key messages in the prescriber guide.
Rivaroxaban (Xarelto, BAY59-7939)
Survey to measure patient awareness and understanding of the key messages in the patient card.
Multiple Locations
Multiple Locations
Multiple Locations
Multiple Locations
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
RTI Health Solutions
OTHER
Bayer
INDUSTRY